Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01527981 · ClinicalTrials.gov registry record · Phase 2

Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes

A Phase 2 study of Depression and Type 1 Diabetes, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 2
Development phase
9
Enrollment target
1
Study location

NCT01527981 is a Phase 2 study of Depression and Type 1 Diabetes that has completed, run by Massachusetts General Hospital. The registered enrollment target is 9 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01527981, a Phase 2 study of Depression and Type 1 Diabetes, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 2
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This study is a pilot behavioral intervention trial, designed to initially examine cognitive behavioral therapy for medical adherence and depression (CBT-AD) in patients with depression and poorly controlled type 1 diabetes.

Conditions Studied

Depression Type 1 Diabetes

Interventions

  • BEHAVIORAL Cognitive behavioral therapy for adherence and depression

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2008-03
Est. Completion 2010-11
Phase Phase 2

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01527981

The ClinicalTrials.gov registry entry for NCT01527981 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Cognitive behavioral therapy for adherence and depression is the first listed.

NCT01527981 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01527981 about?

NCT01527981 is a clinical study titled "Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes". This study is a pilot behavioral intervention trial, designed to initially examine cognitive behavioral therapy for medical adherence and depression (CBT-AD) in patients with depression and poorly controlled type 1 diabetes.

What is the current status of trial NCT01527981?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2008-03. Estimated completion is 2010-11.

What conditions does trial NCT01527981 study?

This clinical trial studies the following conditions: Depression, Type 1 Diabetes.

What interventions are being tested in trial NCT01527981?

The interventions under investigation include: Cognitive behavioral therapy for adherence and depression (BEHAVIORAL).

Who is sponsoring clinical trial NCT01527981?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01527981 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Type 1 Diabetes

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.